ArticleFrontiers in surgery2026

SPRAYDYE: a phase I/II randomised pilot study to assess the safety and feasibility of topically applied AKRO-6qcICG, a cathepsin-activatable fluorescent imaging agent, for real-time intraoperative resection margin assessment in breast-conserving surgery.

Cedric M W Pesch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.